Taylor, Jude Matthew <br/><br/>
Soluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood-nerve-barrier permeability and inflammation.  [electronic resource] 

 -  Journal of neuroimmunology  Feb 2007 
 - 118-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0165-5728 
<br/><br/><label>Standard No.: </label>10.1016/j.jneuroim.2006.11.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies--administration & dosage<br/>Blood-Brain Barrier--drug effects<br/>Capillary Permeability--drug effects<br/>Disease Models, Animal<br/>Encephalomyelitis, Autoimmune, Experimental--chemically induced<br/>Female<br/>Inflammation--etiology<br/>Macrophages--drug effects<br/>Male<br/>Myelin Sheath--immunology<br/>Rats<br/>Rats, Inbred Lew<br/>Receptors, Tumor Necrosis Factor, Type I--administration & dosage<br/>Time Factors